Fibroblast Growth Factor 23 is linked to endothelial dysfunction in patients with ESRD [19, 22–24] and FGF-23 levels have been shown to significantly decrease following successful kidney transplantation [15]. The gene discussed is FGF23; the disease is endothelial dysfunction.